NEW YORK, Oct. 13, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky notifies investors that it has commenced an investigation of The Estee Lauder Companies Inc. (“Estee”) (NYSE: EL) concerning possible violations of federal securities laws.
On May 3, 2023, Estee lowered its full year 2023 guidance for the third consecutive time this year erasing almost $900 million from 4Q sales. The Company blamed elevated inventory in China and continued weakness in travel retail due to post-pandemic flying regulations in Asia. Analysts commenting on Estee’s missed guidance raised questions as to the Company’s capabilities relating to forecasting, visibility, and supply-chain agility. Following this news, Estee’s stock price fell by $42.52 per share, or approximately 17% to close at $202.70 per share. . To obtain additional information, go to:
or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
- Goodfood Reports Second Quarter of 2025 Results with Net Sales of $31 million, Gross Profit of $13 million and Adjusted EBITDA¹ of $1 million - April 22, 2025
- Form 8.3 – [ALLIANCE PHARMA PLC – 17 04 2025] – (CGWL) - April 22, 2025
- [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 17 04 2025] – (CGWL) - April 22, 2025
